Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Cytokinesis wikipedia , lookup
Extracellular matrix wikipedia , lookup
Cell growth wikipedia , lookup
Tissue engineering wikipedia , lookup
Cell encapsulation wikipedia , lookup
Cell culture wikipedia , lookup
Cellular differentiation wikipedia , lookup
Organ-on-a-chip wikipedia , lookup
Def-HEP WT Wild Type Human Hepatocytes DefiniGEN has world-leading expertise in the provision of human cell products to the life science and drug discovery sectors. Our hepatocyte cells display the functional characteristics of primary human hepatocyte cells including albumin production, A1AT secretion, glycogen storage and CYP450 expression. The cells also have wild-type donor genetics, karotype and metabolism in contrast to immortalized cell lines. The Def-HEP cells provide customers with a reproducible source of highly functional liver products to enhance their research for key applications including vaccine development, predictive toxicology and disease modelling. The cells are generated using a ground-breaking iPS (induced Pluripotent Stem) cell production platform developed at the University of Cambridge. (1)(2)(3)(4) Hepatocyte cell morphology: The Def-HEP cell products are highly functional human hepatocytes. Advantages When thawed and plated as a monolayer Def-HEP cells form hepatocytes with cobblestone morphology and tight cell junctions. - Standardized cell product containing >98% human hepatocyte cells producing reproducible and biologically relevant data - Normal human genetics wild-type donor genetics and karotype verified Figure 1. Overview of Def-HEP cell morphology. Def-HEP WT cells exhibit typical hepatocyte cobblestone morphology and bi-nucleation. Gene expression profiles: Def-HEP cells express key hepatocyte markers including albumin, A1AT and HNF4a at similar levels to Primary Human Hepatocytes. Significantly the observed AFP (Alfa-fetoprotein levels) are very low in the Def-HEP cells indicating they have progressed to a mature state comparable to PHH. - Human hepatocyte function Def-HEP are functionally mature hepatocytes which can be plated and maintain function over a 10 day window - Optimized work flow we can deliver industrial quantities of cryopreserved cell products to client specification Hepatocyte key marker analysis 2.500 1.500 1.000 0.500 0.000 Def-HEP WT PHH HEP G2 Albumin +++ +++ ++ A1AT +++ +++ ++ Glycogen Storage +++ +++ ++ Urea ++ +++ - Induction multiple CYP450 ++ +++ - Phase II enzymes ++ +++ - +++ +++ - - - +++ Functional Characteristics 2.000 Def HEP WT PHH AAT AFP ALB HEP G2 HNF4a Normal WT genetics and karotype Figure 2. Gene expression analysis demonstrates that Def-HEP express key hepatocyte markers at similar levels to PHH. AFP levels are extremely low in Def-HEP indicating the cells have attained a functional mature status. Crabtree effect References: 1. Hannan NR, Vallier L et al. Production of hepatocyte-like cells from human pluripotent stem cells. Nature Protocols. 2013 Feb;8(2):430-7. 2. Yusa K, Rashid ST, Vallier L, et al. Targeted gene correction of a1- antitrypsin deficiency in induced pluripotent stem cells. Nature. 2011; 478; 391-4. 3. Rashid ST, Vallier et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest. 2010;120:3127-36. 4. Takahashi K & Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126; 663-676. Supported By Hepatocyte maturation markers: Def-HEP cells display the functional characteristics of primary human hepatocytes including albumin secretion, A1AT production, glycogen storage and LDL uptake (Figure 3). Accordingly they should be handled in a similar Metabolism - absence of Crabtree effect: fashion to primary human hepatocytes. Dosing Def-HEP WT with +/- glucose media does not alter the hepatotoxic effect of chlorpromazine as assessed via the MTT cell proliferation assay. Therefore, it is highly unlikely that our cells exhibit the Crabtree effect, in contrast to immortalized lines. Figure 3. Functional analysis of Def-HEP WT hepatocytes. (a) Albumin secretion, 10x magnification (b) Glycogen storage shown by PAS staining (c) LDL cholesterol uptake shown by fluoresceinated LDL incorporation. Multiple CYP450 activities: Def-HEP exhibit multiple drug-metabolizing CYP450 enzyme activities at levels comparable to PHH. In addition the CYP450 induction levels observed upon exposure to inducers is similar to PHH (n=3). Figure 6. Confirmation of absence of the Crabtree effect in Def-HEP WT. Mitochondrial toxicity: As assessed by dosing Def-HEP WT with valinomycin (0.3 - 600nM) and papverine (0.03 - 60 μM) for 48 hr both compounds caused significant mitochondrial toxicity within concentration ranges recognised in literature. Cell viability was assessed via the CellTiter 96® Aqueous Non-Radioactive Cell. Both papaverine and valinomycin caused significant mitochondrial toxicity. Figure 4. Multiple CYP activites of cryopreserved Def-HEP hepatocyte cells. The results show Def-HEP cells have comparable CYP activity to PHH and induced activity profiles that are similar to PHH (CYP1A2 EROD assay inducer Omeprazole), (CYP450 PGlo assay inducer rifampicin). Figure 7. Typical Def-HEP WT mitochondrial toxicology drug response to valinomycin and papverine. Ordering Information Product Specification Hepatitis marker analysis: There is currently no effective vaccine for hepatitis C and the future Catalog Number Def-HEP WT development of vaccinations and antiviral therapies for this disease relies Format Cryopreserved 10 million cells per vial upon the development of a suitable cell model. HCV entry requires sequential Viability > 70% Applications Research and Predictive Toxicology factors including CD81, SR-B1, claudin-1 and occludin. Def-HEP have been demonstrated to express these key markers at levels similar to PHH. Usage Statement: The products are provided for research use only and are not to be utilized for unauthorised commercial purposes including ex vivo or in vivo therapeutic uses in humans. Figure 5. Gene expression analysis demonstrating the presence of key Hepatitis C markers in Def-HEP including SR-B1, CD81, Claudin-1 and Occludin. Supported By Contact Information: DefiniGEN Ltd, Babraham Research Campus, Moneta B280, Cambridge, CB22 3AT Email: enquiries@definigen.com, Telephone: +44 (0) 1223 497 113 Website: www.definigen.com